MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Depression"

  • 2024 International Congress

    Suicide risk relationship with motor and non-motor symptoms in patients with Parkinson’s disease.

    I. Estrada-Bellmann, A. Ontiveros -Sanchez, R. Trejo-Ayala, G. Porras-Garza, L. Dela Garza, G. Sanchez-Torres, R. Ruiz-Meza, P. Cortes-Estrada (MONTERREY, Mexico)

    Objective: Determine Suicide Risk relationship with motor and non motor symptoms in patients with Parkinson´s disease. Background:  Suicidal ideation is increased in people with Parkinson's…
  • 2024 International Congress

    Efficacy of Audiovisual Neuromodulation in the Treatment of Parkinson’s Disease

    O. Alenikova, L. Parkhach, E. Bоsiakova, G. Zobnina (Minsk, Belarus)

    Objective: To evaluate the AVS effectiveness in depression, anxiety, autonomic disorders and visual dysfunction in PD patients. Background: The severity of non-motor dopa-resistant symptoms in…
  • 2024 International Congress

    Neurophysiological Underpinnings of Apathy in Parkinson’s Disease Versus Depressive Disorders: A Comparative Study

    D. Nolasco, A. Sohel, B. Carr (Gainesville, USA)

    Objective: The manifestation of apathy in neurological and psychiatric conditions such as Parkinson's Disease (PD) and depressive disorders presents a significant clinical challenge. This study…
  • 2024 International Congress

    Effect Of Botulinum Toxin On Non-Motor Symptoms In Adult-Onset Idiopathic Focal Dystonia

    S. Mehta, R. Gupta, N. Balaini, S. Grover, V. Lal (Chandigarh, India)

    Objective: To assess the effect of Botulinum toxin on non-motor symptoms and quality of life in patients with adult-onset idiopathic focal dystonia. Background: A broad…
  • 2024 International Congress

    Listening to the Insight: The Underdiagnosis of Depression in People Living with Parkinson’s Disease

    G. Rivera-Monroy, RJ. Baños-Betancourt, K. Velázquez-Román, CF. álvarez-Hernández, AL. Guerra-Anzaldo, WF. Moguel-Cardín, A. Domínguez-García, MF. Medina-Pérez, JC. Delgado-Uriarte, NP. Moreno-Aldama, A. Uribe-León, MC. Unda-Mcfarlane, AJ. Hernández-Medrano, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico City, Mexico)

    Objective: To determine the prevalence of risk of undiagnosed depression among people living with Parkinson's disease (PwP) without a prior depression diagnosis. Background: Parkinson's disease…
  • 2024 International Congress

    Clinical and Epidemiological Aspects of Neuropsychiatric Features in Patients with Huntington Disease in Chile

    J. Fuentes, P. Salles, P. Chaná-Cuevas, C. Montalva, M. Sánchez, N. Rojas (Santiago, Chile)

    Objective: To describe the prevalence of motor and neuropsychiatric symptoms in HD patients seen at the Center of Movement Disorders (CETRAM), Santiago, Chile. Background: There…
  • 2024 International Congress

    Neuropsychiatric symptoms in patients with probable Progressive supranuclear palsy in reference centers of Valle del Cauca- Colombia

    V. Martínez-Villota, L. Ortega-Bolaños, C. Hurtado-Gonzalez (Pasto, Colombia)

    Objective: To evaluate the neuropsychiatric symptoms in patients with probable Progressive supranuclear palsy attended in reference centers  of the Valle del Cauca, Colombia, between 2020 and…
  • 2024 International Congress

    Apathy in de novo Parkinson’s disease improves after the first years with dopaminergic treatment.

    A. Castrioto, M. Anheim, E. Schmitt, S. Meoni, JL. Houeto, H. Klinger, D. Sourd, P. Pelissier, E. Lhommee, C. Tranchant, JP. Azulay, F. Durif, E. Moro, V. Fraix, S. Thobois, P. Krack (Grenoble, France)

    Objective: to define the evolution of apathy and other neuropsychiatric symptoms in patients with early Parkinson’s disease (PD). Background: Apathy is a common neuropsychiatric symptom…
  • 2024 International Congress

    Measuring Cortisol Levels in Persons with Huntington’s Disease

    A. Clarke, B. Lobb, A. Hiller (Portland, USA)

    Objective: To assess subjective and objective measures of emotional stress via standardized scales and a physiological measure (salivary cortisol) in persons with Huntington’s Disease (HD)…
  • 2024 International Congress

    The Clinical Landscape of Progressive Supranuclear Palsy in an Underserved Community from Southwestern Colombia

    L. Ortega-Bolaños, G. Pinilla-Monsalve, V. Martinez-Villota (Cali, Colombia)

    Objective: To elucidate the clinical presentation of Progressive Supranuclear Palsy (PSP) in a cohort residing in underserved communities in Buenaventura, Colombia—the country's primary maritime port…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 32
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley